Insulin stimulation of adipocytes results in serine phosphorylation/ activation of phosphodiesterase 3B (PDE 3B) and activation of a kinase that phosphorylates PDE 3B in vitro, key events in the antilipolytic action of this hormone. We have investigated the role for p70 S6 kinase, mitogen-activated protein kinases (MAP kinases), and protein kinase B (PKB) in the insulin signaling pathway leading to phosphorylation/activation of PDE 3B in adipocytes. Insulin stimulation of adipocytes resulted in increased activity of p70 S6 kinase, which was completely blocked by pretreatment with rapamycin. However, rapamycin had no effect on the insulin-induced phosphorylation/ activation of PDE 3B or the activation of the kinase that phosphorylates PDE 3B. Stimulation of adipocytes with insulin or phorbol myristate acetate induced activation of MAP kinases. Pretreatment of adipocytes with the MAP kinase kinase inhibitor PD 98059 was without effect on the insulin-induced activation of PDE 3B. Furthermore, phorbol myristate acetate stimulation did not result in phosphorylation/activation of PDE 3B or activation of the kinase that phosphorylates PDE 3B. Using Mono Q and Superdex chromatography, the kinase that phosphorylates PDE 3B was found to co-elute with PKB, but not with p70 S6 kinase or MAP kinases. Furthermore, both PKB and the kinase that phosphorylates PDE 3B were found to translocate to membranes in response to peroxovanadate stimulation of adipocytes in a wortmannin-sensitive way.
I
NSULIN PLAYS a key role in the regulation of lipid and carbohydrate metabolism in many mammalian cells, principally liver, muscle, and adipocytes. Despite recent substantial advances in the understanding of intracellular signaling, the detailed mechanisms by which insulin regulates these metabolic processes are still unclear. One important metabolic action of insulin is to block hydrolysis of stored triglycerides in adipocytes. The antilipolytic action of insulin can to a large extent be explained by the ability of this hormone to lower intracellular cAMP levels, resulting in reduction in the activity of cAMPdependent protein kinase, net dephosphorylation, and deactivation of hormone-sensitive lipase, and thereby inhibition of lipolysis (1) (2) (3) (4) . In rat adipocytes, insulin-mediated reduction of cAMP/cAMP-dependent protein kinase is mainly mediated through phosphorylation (serine 302) (5) and activation of phosphodiesterase 3B (PDE 3B) (6) .
With the use of wortmannin, a selective inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase), it has been suggested that PI 3-kinase is involved in the antilipolytic action of insulin (7) . Pretreatment of adipocytes with wortmannin inhibits phosphorylation/activation of PDE 3B, blocks the insulin-induced activation of a kinase that phosphorylates PDE 3B (8) and the antilipolytic action of insulin (7, 8) . However, the components in the signaling pathway between PI 3-kinase and PDE 3B, including the kinase responsible for the phosphorylation of PDE 3B, have not been identified.
Mitogen-activated protein kinases (MAP kinases) (9) , p70 S6 kinase (10) and protein kinase B (PKB), also known as RAC or Akt kinase (11) , are activated in response to insulin stimulation of adipocytes (12) (13) (14) (15) (16) through wortmannin-sensitive mechanisms (15) (16) (17) (18) (19) . Thus, these kinases could have a role in the signaling pathway between PI 3-kinase and PDE 3B. In this report, we show that insulin-induced activation of p70 S6 kinase and MAP kinases are not involved in the phosphorylation/activation of PDE 3B. However, our results strongly suggest that PKB is responsible for the phosphorylation of PDE 3B in vitro, and thereby constitutes a likely candidate involved in the insulin-induced antilipolytic signaling pathway in adipocytes. A minor part of these results has previously been reported in abstract form (20) . (Aurora, OH). Antibodies against p70 S6 kinase were from Santa Cruz Biotechnology (Santa Cruz, CA) and antibodies against MAP kinases and PKB were from Upstate Biotechnology Inc. (Lake Placid, NY). Polyclonal antibodies against PDE 3B were raised in rabbits using a PDE 3B peptide (LRRSSGASGLLTSEHHSR) as previously described (21) . The peptide KKRNRTLTK was synthesized at the Biomolecular Unit, Lund University, Sweden.
32 P i was from Amersham, Little Chalfont, UK and [␥- 32 P]ATP was synthesized as described (22) . Protein A Sepharose was from Pharmacia (Uppsala, Sweden).
Preparation and stimulation of adipocytes
Adipocytes were prepared from the epididymal adipose tissue of 36-to 38-day-old male Sprague-Dawley rats (B&K Universal, Stockholm, Sweden) according to the method of Rodbell (23) with modifications described by Honnor et al. (24) . Cells were suspended in Krebs-Ringer medium, pH 7.4, containing 25 mm HEPES, 200 nm adenosine, 2 mm glucose, and 1% BSA. PMA, PD 98059, rapamycin and wortmannin were dissolved in dimethylsulfoxide and added to cells resulting in a final concentration of dimethylsulfoxide of less than 0.15%. Peroxovanadate was prepared fresh by mixing 300 mm vanadate and 790 mm H 2 O 2 (final concentration; 12 mm of each) in 40 mm HEPES, pH 7.4, and incubating the mixture at 20 C for 15 min. Adipocytes (1.5-2 ml 10% cell suspension) were incubated at 37 C with various agents, centrifuged, and resuspended in 5-10 ml of homogenization buffer consisting of 50 mm N-tris [Hydroxymetyl] metyl-2-aminoethanesulfonic acid (TES), pH 7.5, 2 mm EGTA, 1 mm EDTA, 250 mm sucrose, 40 mm phenyl phosphate, 5 mm NaF, 1 mm phenylmethylsulfonylfluoride, 0.05 mm sodiumvanadate, 1 mm dithioerythritol (DTE), antipain (10 g/ml), leupeptin (10 g/ml), and pepstatin A (1 g/ml). Cells were centrifuged a second time, suspended in homogenization buffer (1.0 ml final volume), homogenized (10 strokes) at room temperature, and placed on ice. The homogenates were centrifuged at 50,000 ϫ g for 60 min at 4 C. Fat-free supernatants (referred to as cytosol fractions) were withdrawn. To determine PDE 3B activity, the membrane fractions were resuspended in 0.4 ml of 50 mm Tris, pH 7.5, 5 mm MgCl 2 , 1 mm EDTA, 5% (wt/vol) glycerol, antipain (10 g/ml), leupeptin (10 g/ml) and pepstatin A (1 g/ml) and assayed as previously described (8) . In experiments where translocation of PKB and the kinase that phosphorylates PDE 3B was investigated, the membrane fractions were resuspended in 1.0 ml of homogenization buffer. Adipocytes (2 ml of 10% cell suspension) were labeled with 32 P i (1 mCi/ml) for 1 h 15 min and after stimulation, PDE 3B was immunoisolated from solubilized membrane fractions as previously described (8) . The PDE 3B antibodies quantitatively immunoprecipitated PDE 3B from both control and insulin-stimulated cells.
Immunoprecipitation of p70 S6 kinase
Cytosol fractions (400 l; equivalent to 80 l packed cells) from control and stimulated cells were immunoprecipitated with a polyclonal antibody against p70 S6 kinase (1 g IgG). After 16 h incubation at 4 C, protein A Sepharose (35 l 50% suspension) was added, and the incubation continued for 2 h. After centrifugation, the immunoprecipitates were washed twice with PBS, twice with homogenization buffer, resuspended in 20 l of homogenization buffer, and assayed for kinase activity. One tenth of the immunoprecipitates were mixed with Laemmli sample buffer (25) and subjected to SDS-PAGE, followed by electrotransfer of proteins onto polyvinylidene difluoride membrane (Millipore, Bedford, MA). After blocking with 0.5% gelatin in PBS with 0.1% Tween 20, the membrane was incubated with a 1:1000 dilution of the p70 S6 kinase antibody followed by a horseradish peroxidase-conjugated secondary antibody; protein was detected with Amersham's enhanced chemiluminescence system.
Protein kinase assays
The activity of p70 S6 kinase was determined in 15 l immunoprecipitates (equivalent to 60 l packed cells, see above) by incubation with 7.5 l of a phosphorylation mixture containing 150 m [␥- 32 PKB activity was determined in 10 l of cytosol fractions or chromatography fractions by incubation for 10 min at 30 C with 5 l of the phosphorylation mixture containing 13.3 g of the peptide KKRN-RTLTK as substrate, as described above. Although these conditions are essentially the same as for determining p70 S6 kinase activity, we have found that the kinase activity detected in cytosol fractions from insulinstimulated adipocytes can, to a large extent (Ն95%), be attributed to PKB with no significant contribution by p70 S6 kinase (see Ref. 16) .
Activity of the MAP kinases were determined in an in-gel assay by subjecting cytosol fractions (100 l; equivalent to 20 l packed cells) to SDS-PAGE (13% polyacrylamide) (0.75-mm thick gels) with MBP (0.5 mg/ml) in the separating gel. Subsequent to electrophoresis, gels were treated as described by Kameshita and Fujisawa (26) and modifications described by Cano et al. (27) . The kinase assay was initiated by addition of 10 ml buffer consisting of 40 mm HEPES, pH 8.0, 1 mm DTE, 9 mm MgCl 2 , 0.2 mm EGTA, and 40 m [␥-32 P]ATP (100 Ci) to the gels. After incubation at room temperature for 1 h, the gels were washed five times with 5% (wt/vol) trichloroacetic acid and 1% (wt/vol) sodium pyrophosphate, dried, and 32 P incorporated into MBP was visualized by digital imaging (Fujix BAS 2000) .
Kinase activity, with solubilized PDE 3B as substrate, was measured in cytosol fractions (70 l, equivalent to 20 l packed cells) or, in some cases, resuspended membrane fractions, as described previously (8) .
Mono Q and Superdex chromatography
Cytosol fractions from control and insulin-stimulated adipocytes (equivalent to 1.4 ml of packed cells) were chromatographed on a Mono Q HR 5/5 FPLC column equilibrated in 50 mm TES, pH 7.5, 2 mm EGTA, 1 mm EDTA, 5% (wt/vol) glycerol, 40 mm phenyl phosphate, 5 mm NaF, 1 mm DTE, 0.15 mm phenylmethylsulfonylfluoride, 0.05 mm sodiumvanadate (Buffer A). After a 15-ml wash, the column was eluted with a 40-ml gradient of 0 -700 mm NaCl in buffer A at a flow rate of 1 ml/min and 1.5 ml fractions were collected. Fractions were assayed for in vitro phosphorylation of PDE 3B as well as subjected to SDS-PAGE and immunoblot analysis with a 1:1000 dilution of antibodies against either PKB, or p70 S6 kinase, or MAP kinases.
Selected fractions from the Mono Q chromatography were concentrated and subjected to gel filtration chromatography on a Superdex 75 HR 10/30 FPLC column equilibrated in buffer A containing 150 mm NaCl. The column was eluted at a flow rate of 0.5 ml/min and 0.5 ml fractions were collected. Fractions were assayed for in vitro phosphorylation of PDE 3B as well as subjected to SDS-PAGE and immunoblot analysis with antibodies against either PKB or MAP kinases.
Results

Effects of insulin, rapamycin, PD 98059, and PMA on phosphorylation/activation of PDE 3B and activation of the kinase that phosphorylates PDE 3B
Insulin stimulation of adipocytes has previously been shown to induce phosphorylation of PDE 3B (serine 302), which is associated with activation of the enzyme (6, 8, 28) . In adipocytes, an insulin-stimulated kinase that phosphorylates PDE 3B has been detected, although not identified (8) . Both the insulin-induced phosphorylation/activation of PDE 3B and the activation of the kinase are inhibited by wortmannin, indicating that the signal is mediated via PI 3-kinase (8) . We have investigated p70 S6 kinase, MAP kinases, and PKB, kinases that are activated by insulin in a wortmanninsensitive manner, as potential candidates involved in the insulin-stimulated signaling pathway leading to phosphorylation/activation of PDE 3B.
Rapamycin was used to evaluate the role of p70 S6 kinase in the phosphorylation/activation of PDE 3B. Pretreatment of adipocytes with rapamycin had no effect on the insulininduced phosphorylation (Fig. 1A) or activation (Table 1) of PDE 3B. Furthermore, rapamycin did not inhibit insulininduced activation of the kinase that phosphorylates PDE 3B (Fig. 1B) . The 1.4-fold increase in activity of PDE 3B seen in response to insulin stimulation (Table 1) is somewhat low compared with the 1.5-to 3-fold activation previously reported for adipocytes (8, 28, 29) . An explanation for this difference could be that the buffer we have used to homogenize the adipocytes was not optimized to measure activation of PDE 3B and contains, e. g. DTE, which has been shown to lower the insulin-induced activation of PDE 3B without affecting the basal activity, thereby lowering the fold activation (29) . To confirm that rapamycin inhibited the insulininduced activation of p70 S6 kinase, experiments were performed to measure kinase activity in immunoprecipitates of p70 S6 kinase. As seen in Fig. 2 , insulin induced activation of p70 S6 kinase (partial activation after 5 min and maximal activation after 15-min stimulation), which was completely inhibited by rapamycin. Pretreatment with wortmannin also inhibited the insulin-induced activation of p70 S6 kinase. These results indicate that p70 S6 kinase, although activated by insulin in a wortmannin-sensitive manner, is not involved in the signaling pathway that leads to phosphorylation/ activation of PDE 3B.
To evaluate the role of MAP kinases in the phosphorylation/activation of PDE 3B, we investigated the effect of PMA, a potent activator of MAP kinases, and the effect of the MAP kinase kinase inhibitor PD 98059, which blocks activation of MAP kinases in intact cells (30) . Using an in-gel kinase assay with MBP as substrate, control experiments were performed to confirm activation of MAP kinases in adipocytes. Both insulin and PMA stimulation revealed activation of the MAP kinases p42 and p44 (Fig. 3) . While the insulin-induced activation of these MAP kinases was completely blocked by wortmannin, the PMA-induced activation was unaffected by FIG. 1. Effect of insulin, rapamycin, and PMA on the phosphorylation of PDE 3B and activation of the kinase that phosphorylates PDE 3B in vitro. A, Adipocytes were prelabeled with 32 P and, following stimulation with the indicated agents, PDE 3B was immunoprecipitated, subjected to SDS-PAGE, and incorporation of 32 P into PDE 3B was visualized by digital imaging of 32 P, Fujix BAS 2000. B, Adipocytes were stimulated with the indicated agents and cytosol fractions were prepared and assayed for kinase activity with [␥-32 P]ATP and PDE 3B as substrate. PDE 3B was immunoprecipitated and subjected to SDS-PAGE, and 32 P incorporation into PDE 3B was visualized by digital imaging of 32 the inhibitor. The activation of the MAP kinases in response to insulin showed some variation between different experiments (2-to 5-fold); however, it was always less pronounced than that induced by PMA (8-fold).
Pretreatment of adipocytes with PD 98059 did not block the insulin-induced activation of PDE 3B (Table 1) , or the activation of the kinase that phosphorylates PDE 3B (results not shown). Under the same conditions, PD 98059 inhibited the insulin-induced activation of MAP kinases by 71 Ϯ 3% (mean Ϯ sem of three separate experiments) (Fig. 3) . The same extent of inhibition was also seen when kinase activity was determined in immunoprecipitates of MAP kinases (results not shown). Increasing the concentration of the inhibitor (150 m) or incubation time (60 min) reduced the basal activity of MAP kinases but did not result in higher extent of inhibition of the insulin-induced activation of MAP kinases. Although PMA induced activation of MAP kinases to a greater extent than insulin, it did not result in phosphorylation/activation of PDE 3B (Fig. 1A and Table 1 ) or activation of the kinase that phosphorylates PDE 3B (Fig. 1B) . Using higher concentrations of PMA (450 nm) or extending the time of exposure to PMA (20 min) did not result in activation of PDE 3B (not shown). Taken together, these results suggest that MAP kinases are not involved in the phosphorylation/ activation of PDE 3B.
Mono Q and Superdex chromatography of the kinase that phosphorylates PDE 3B: comparison with PKB, p70 S6 kinase and MAP kinases
We and others (15, 16, 19) have recently shown that PKB is activated in a wortmannin-sensitive manner in intact adipocytes in response to insulin stimulation and could thus be involved in the signaling pathway leading to phosphorylation/activation of PDE 3B. Because inhibitors of PKB are not yet available, the role of PKB in the insulin-induced antilipolytic pathway cannot easily be investigated in the intact cell. To investigate the role of PKB as a PDE 3B kinase, FIG. 3 . In-gel kinase assay of cytosol fractions from stimulated adipocytes with MBP as substrate. Adipocytes were incubated in the presence or absence of 100 nM wortmannin for 10 min or 50 M PD 98059 for 20 min followed by stimulation with 1 nM insulin or 150 nM PMA for the indicated times. Cytosol fractions were prepared and subjected to electrophoresis in a polyacrylamide gel containing MBP. Following renaturation of the proteins, kinase activity was determined as described in Materials and Methods. The position of p42 and p44 are indicated to the right and the position of molecular weight markers to the left. The intensity of the p42 plus p44 bands from the in-gel kinase assay, expressed as percent of control (taken as 100%), are shown at the bottom. The kinases corresponding to molecular weights of about 60, 120, and 130 kDa did not show any increase in activity in response to neither PMA nor insulin. Contr, control; Wort, wortmannin; PD, PD 98059; Ins, insulin.
attempts were made to immunoprecipitate PKB from adipocytes to be used in an immunocomplex kinase assay with PDE 3B as substrate. Despite the use of several different antibodies against PKB, significant immunoprecipitation of PKB from adipocytes was not successful although these antibodies immunoprecipitated PKB from extracts of 3T3-L1 cells, rat liver, and PKB expressed in yeast (16) . However, it has not been possible to obtain activated PKB from these sources. Therefore, to evaluate the possibility that PKB is the kinase that phosphorylates PDE 3B in vitro, other approaches were used.
Mono Q and Superdex chromatrographies were performed and the elution profiles of PKB and the kinase that phosphorylates PDE 3B were compared. As shown in Fig.  4A , chromatography of cytosol fractions from control and insulin-stimulated adipocytes on a Mono Q column revealed insulin-stimulated kinase activity, assayed with PDE 3B as substrate, eluting as a single peak at approximately 0.15 m NaCl (mainly fractions 19 and 20) . No kinase activity phosphorylating PDE 3B was detected in Mono Q fractions from control cells. Immunoblot analysis of the Mono Q fractions with antibodies against PKB (Fig. 4B ) revealed elution of PKB from insulin-stimulated cells in the same fractions as the kinase that phosphorylates PDE 3B. These fractions also showed increased PKB activity (see legend to Fig. 4) . As noted previously, PKB protein from insulin-stimulated cells eluted at a higher salt concentration from the Mono Q column and showed reduced electrophoretic mobility on SDS-PAGE compared with PKB from control cells (16) . The reduced electrophoretic mobility of stimulated PKB has been linked to phosphorylation of the kinase (31) . Reprobing the membranes with antibodies against MAP kinases (Fig. 4D) revealed MAP kinases eluting in the same fractions as PKB (fractions 19 and 20) . p70 S6 kinase eluted later in the gradient (fractions 24 -26) (Fig. 4C) , and no kinase activity phosphorylating PDE 3B was detected in these Mono Q fractions (not shown). The inability of p70 S6 kinase to phosphorylate PDE 3B in vitro is consistent with the finding that rapamycin had no effect on the insulin-induced phosphorylation/activation of PDE 3B in vivo (Fig. 1A and Table 1 ).
Subsequent chromatography (fractions 17 and 18 from control and fractions 19 and 20 from insulin-stimulated cells) on a gel filtration column revealed elution of both PKB (Fig.  5B ) and the kinase that phosphorylates PDE 3B (Fig. 5A) fraction 21 (corresponding to a molecular mass of about 60 kDa), whereas MAP kinases eluted in fractions 22 and 23 (Fig. 5C) . Thus, from two consecutive chromatographies, the kinase that phosphorylates PDE 3B co-eluted with PKB, suggesting that PKB is responsible for the phosphorylation of PDE 3B.
Translocation to membranes of PKB and the kinase that phosphorylates PDE 3B in response to peroxovanadate stimulation
To further strengthen the hypothesis that the kinase that phosphorylates PDE 3B is PKB and not a comigrating kinase, we took advantage of a recent finding that PKB becomes activated and translocates from cytosol to membranes, in a wortmannin-sensitive manner, as a result of peroxovanadate stimulation of adipocytes (16) . Peroxovanadate is a well known phosphotyrosine phosphatase inhibitor (32) and has been shown to mimic insulin action at least in part by activating the insulin receptor tyrosine kinase and by increasing the tyrosine phosphorylation of insulin receptor substrate 1 and 2 (33, 34) . As shown in Fig. 6 , peroxovanadate stimulation of adipocytes induced a wortmannin-sensitive translocation to membranes of PKB (cf 16) as well as of the kinase that phosphorylates PDE 3B. The concentration of peroxovanadate was chosen to be in the range where wortmannin pretreatment did not efficiently prevent peroxovanadateinduced activation of PKB and the kinase that phosphorylates PDE3B (see Discussion). Insulin stimulation also resulted in activation of PKB as well as the kinase that phoshorylates PDE 3B; however, insulin stimulation did not induce translocation to membranes (Fig. 6, lane 2) . MAP kinases have been shown to translocate to the nucleus in response to growth factor stimulation (35) . Immunoblotting of cytosol and membrane fractions from adipocytes with antibodies against MAP kinases revealed MAP kinases almost exclusively (more than 95%) in the cytosol fraction, with no indication of translocation to membranes in response to insulin or peroxovanadate stimulation (results not shown). Thus, data from the chromatographies and the subcellular translocation experiments strongly suggest that PKB is the kinase that phosphorylates PDE 3B.
Discussion
PDE 3B has previously been identified as a key component in insulins' antilipolytic signaling pathway. Insulin-mediated phosphorylation/activation of PDE 3B leads to lowering of cAMP/cAMP-dependent kinase that results in netdephosphorylation and thereby inactivation of hormonesensitive lipase, the rate limiting step in lipolysis (1) (2) (3) (4) (5) . Because the antilipolytic effect of insulin, including the activation of the kinase that phosphorylates PDE 3B and the phosphorylation/activation of PDE 3B, is blocked by wortmannnin, PI 3-kinase has been suggested to be an important upstream component in this signaling pathway (8) . PI 3-kinase has been shown to have not only lipid kinase activity but also serine protein kinase activity (36) . Attempts to phosphorylate/activate PDE 3B by PI 3-kinase immunoisolated from insulin-stimulated rat adipocytes has not been successful, suggesting that additional kinase(s) are required to mediate the signal between PI 3-kinase and PDE 3B. p70 S6 kinase, MAP kinases, and PKB are activated in response to insulin in adipocytes in a wortmannin-sensitive manner (15) (16) (17) (18) (19) , suggesting that they could have a role in the insulininduced phosphorylation/activation of PDE 3B.
From the present work, we conclude that p70 S6 kinase is not involved in this signaling pathway because rapamycin did not prevent the insulin-induced phosphorylation/activation of PDE 3B or the activation of the kinase that phosphorylates PDE 3B, whereas it completely blocked the insulin-induced activation of p70 S6 kinase. We also conclude that MAP kinases are not involved in the insulin-induced signaling leading to activation of PDE 3B. The specific MAP kinase kinase inhibitor PD 98059 did not prevent insulininduced activation of PDE 3B under conditions where the inhibitor blocked 70% of the insulin-induced activation of MAP kinases. However, we find it less likely that the residual MAP kinase activity is able to mediate maximal phosphorylation/activation of PDE 3B because extensive MAP kinase activation induced by PMA was not associated with phosphorylation/activation of PDE 3B or activation of the kinase that phosphorylates PDE 3B in vitro. In 3T3 cells (30) and 3T3-L1 adipocytes (37), the insulin-induced activation of MAP kinases has been shown to be completely inhibited by PD 98059. We do not know the reason for the incomplete inhibition of the activation of MAP kinases in primary adipocytes, but one possibility could be that these cells also contains other isoforms of MAP kinase kinase, such as MAP kinase kinase 2, which has been shown to be less sensitive to inhibition by PD 98059 (30) .
Our data reported here strongly suggest that the insulinstimulated kinase that phosphorylates PDE 3B in vitro is PKB. A rapid, reversible, and wortmannin-sensitive activation of PKB in response to insulin stimulation of primary adipocytes has recently been reported by us and others (15, 16, 19) . Translocation has been suggested to be important in the activation mechanism of PKB that most likely is due to association between the pleckstrin homology domain of PKB and 3-phosphorylated phosphoinositides generated by PI 3-kinase (11) . The 3-phosphorylated phosphoinositides have also been suggested to induce a conformational change of PKB leading to exposure of sites that are phosphorylated by upstream kinase(s) resulting in activation of PKB (38, 39) . In a previous study we investigated the peroxovanadate-induced activation and membrane translocation of PKB under conditions where wortmannin pretreatment prevented both of these processes (16) . However, we have also found that by increasing the concentration of peroxovanadate, eventually the activation of PKB cannot be prevented by wortmannin pretreatment of the adipocytes (results not shown). This is most likely due to the ability of high concentrations of peroxovanadate to induce dramatic translocation of PI 3-kinase to insulin receptor substrate 1, resulting in high activation of PI 3-kinase (Castan, I., unpublished results) and thereby presumably generation of large amounts of 3-phosphorylated phosphoinositides. The concentration of peroxovanadate that induces the apparent wortmannin-insensitive activation of PKB varies between preparations of peroxovanadate and is probably due to the formation of different amounts of peroxovanadate when mixing vanadate and H 2 O 2 but is usually found in the range of 50 m. In the present study, activation of PKB and the kinase that phosphorylates PDE 3B FIG. 6. Peroxovanadate-induced translocation of PKB and the kinase that phosphorylates PDE 3B to membranes. Adipocytes (1.5 ml 10% cell suspension) were stimulated, and cytosol and membrane fractions were prepared as described in Materials and Methods. Portions (70 l) of the cytosol and membrane fractions were assayed for kinase activity with [␥-32 P]ATP and PDE 3B as substrate. PDE 3B was immunoprecipitated, subjected to SDS-PAGE, and 32 P incorporation into PDE 3B was visualized by digital imaging of 32 was induced by a high peroxovanadate concentration and pretreatment with wortmannin did not significantly prevent the activation of PKB (measured as reduction of electrophoretic mobility) or the activation of the kinase that phosphorylates PDE 3B but still prevented peroxovanadate-induced translocation. This suggests that the translocation process detected requires formation of more 3-phosphorylated phosphoinositides than the activation mechanism. Although insulin stimulation did not induce detectable translocation of PKB to membranes, it is possible that it occurs but is transient or reversed during homogenization and therefore difficult to detect.
Although information regarding the activation of PKB by insulin and growth factors has been obtained in a variety of cells, little is known about downstream targets for PKB. The first physiological substrate reported for PKB was glycogen synthase kinase-3 (40) . Glycogen synthase kinase-3 is inactivated as a result of phosphorylation by PKB in vitro (40) , and in L6 myotubes insulin-induced increase in glycogen synthesis has been suggested to be partially mediated by this mechanism (41) . Most recently, it was reported that heart 6-phosphofructo-2-kinase was phosphorylated and activated by PKB in vitro (42). 6-phosphofructo-2-kinase catalyses the formation of fructose 2,6-bisphosphate, a key allosteric activator of 6-phosphofructo-1-kinase and the rate-limiting enzyme in glycolysis. A role for PKB in the translocation of Glut 4 to plasma membrane and increased glucose uptake has been suggested in 3T3-L1 adipocytes (43) and most recently also in rat adipocytes (44) . The involvement of PKB is not restricted to metabolic actions because it has also been implicated in cell growth (45) and differentiation (43, 46) and data support that p70 S6 kinase is downstream of PKB (47), although not a direct substrate for PKB.
The conclusion that PDE 3B is a substrate for PKB in vitro is supported by results using a combination of methodologies. First, we found that during two consecutive chromatographies, PKB comigrated with the kinase that phosphorylates PDE 3B. Furthermore, upon peroxovanadate stimulation of adipocytes, PKB as well as the kinase that phosphorylates PDE 3B translocated from cytosol to membranes in a wortmannin-sensitive manner. So far we have not been able to detect activation of PDE 3B as a result of in vitro phosphorylation by PKB (Rahn Landströ m, T., unpublished results). One explanation could be that in addition to serine 302, which is the only site phosphorylated in response to insulin stimulation of intact cells and is associated with activation of the enzyme (5), also, other sites are phosphorylated in vitro by partially purified PKB (Rahn Landströ m, T., unpublished results), which could interfere with the activation of PDE 3B. It is also possible that activation of PDE 3B requires additional components such as lipids and proteins which are not present in the in vitro assay. Although our data support that PKB is the kinase that phosphorylates PDE 3B in vitro, the importance of this action of PKB in intact adipocytes remains to be established. This requires specific cell-permeable PKB inhibitors, dominant negative PKBs, or constitutively active PKB to be transfected into adipocytes or 3T3-L1 adipocytes. Such experiments have been initiated.
